Hedge Fund - Roumell Asset Management
Enzo Biochem Inc (ENZ)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q3 (2023-09-30) | $0 | 0% | 0 | $1.51 |
| 2 | 2023 - Q2 (2023-06-30) | $1,253,699 | 2.46% | 681,358 | $2.31 |
| 3 | 2023 - Q1 (2023-03-31) | $2,199,908 | 4.98% | 905,312 | $1.49 |
| 4 | 2022 - Q4 (2022-12-31) | $3,043,418 | 7.53% | 2,128,264 | $1.95 |
| 5 | 2022 - Q3 (2022-09-30) | $5,330,000 | 11.53% | 2,390,211 | $2.42 |
| 6 | 2022 - Q2 (2022-06-30) | $4,948,000 | 9.63% | 2,390,211 | $2.47 |
| 7 | 2022 - Q1 (2022-03-31) | $6,939,000 | 11.21% | 2,392,642 | $3.21 |
| 8 | 2021 - Q4 (2021-12-31) | $7,822,000 | 10.42% | 2,436,771 | $3.41 |
| 9 | 2021 - Q3 (2021-09-30) | $10,219,000 | 13.53% | 2,886,771 | $3.34 |
| 10 | 2021 - Q2 (2021-06-30) | $9,151,000 | 10.69% | 2,886,771 | $3.15 |
| 11 | 2021 - Q1 (2021-03-31) | $9,414,000 | 13.6% | 2,736,719 | $3.11 |
| 12 | 2020 - Q4 (2020-12-31) | $6,979,000 | 10.97% | 2,769,479 | $2.18 |
| 13 | 2020 - Q3 (2020-09-30) | $4,968,000 | 9.84% | 2,354,479 | $2.38 |
| 14 | 2020 - Q2 (2020-06-30) | $1,370,000 | 3.3% | 611,764 | $2.57 |
| 15 | 2019 - Q3 (2019-09-30) | $0 | 0% | 0 | $3.54 |
| 16 | 2019 - Q2 (2019-06-30) | $4,166,000 | 9.86% | 1,236,309 | $3.52 |
| 17 | 2019 - Q1 (2019-03-31) | $5,185,000 | 12.61% | 1,899,179 | $3.27 |
| 18 | 2018 - Q4 (2018-12-31) | $3,072,000 | 6.34% | 1,105,139 | $3.28 |
| 19 | 2018 - Q3 (2018-09-30) | $3,153,000 | 5.78% | 765,284 | $4.54 |
The displayed share prices are average quarterly stock market prices.